EASY BIO,Inc. (KOSDAQ: 353810)
South Korea
· Delayed Price · Currency is KRW
4,535.00
-30.00 (-0.66%)
Dec 20, 2024, 9:00 AM KST
EASY BIO,Inc. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 19,986 | 15,544 | 9,131 | 10,873 |
Depreciation & Amortization | 4,724 | 3,692 | 3,763 | 2,801 |
Loss (Gain) From Sale of Assets | -13.62 | 7.04 | 0.33 | -0.9 |
Loss (Gain) From Sale of Investments | -2,507 | -1,118 | - | - |
Loss (Gain) on Equity Investments | -946.56 | -1,106 | -592.15 | -12.04 |
Provision & Write-off of Bad Debts | -73.88 | -524.94 | 278.77 | 193.34 |
Other Operating Activities | 939.36 | 1,958 | 1,455 | 281.15 |
Change in Accounts Receivable | -3,224 | -82.57 | -5,615 | 5,601 |
Change in Inventory | 2,484 | 3,031 | -4,871 | -2,207 |
Change in Accounts Payable | 415.33 | -23.51 | 1,907 | -1,845 |
Change in Other Net Operating Assets | 27,051 | 12,307 | -13,580 | -1,618 |
Operating Cash Flow | 48,834 | 33,684 | -8,124 | 14,066 |
Capital Expenditures | -5,382 | -1,886 | -1,954 | -1,834 |
Sale of Property, Plant & Equipment | 1,064 | 10.31 | 2.27 | 8.8 |
Cash Acquisitions | -84,819 | - | - | -8,876 |
Sale (Purchase) of Intangibles | -32.21 | -78.45 | -94.69 | -4.53 |
Investment in Securities | -53,433 | -39,386 | 2,561 | -9,354 |
Other Investing Activities | 0 | 0 | -0 | -0 |
Investing Cash Flow | -142,602 | -41,340 | 513.77 | -20,060 |
Short-Term Debt Issued | - | 120,996 | 76,277 | 43,778 |
Long-Term Debt Issued | - | 20,000 | 15,000 | 2,500 |
Total Debt Issued | 190,227 | 140,996 | 91,277 | 46,278 |
Short-Term Debt Repaid | - | -136,441 | -44,695 | -34,394 |
Long-Term Debt Repaid | - | -5,336 | -16,143 | -3,094 |
Total Debt Repaid | -93,153 | -141,778 | -60,838 | -37,488 |
Net Debt Issued (Repaid) | 97,074 | -782.09 | 30,438 | 8,790 |
Dividends Paid | -3,479 | -2,626 | -2,560 | -2,560 |
Other Financing Activities | 664.65 | -0 | - | -0 |
Financing Cash Flow | 91,584 | -3,408 | 27,878 | 6,229 |
Foreign Exchange Rate Adjustments | -609.51 | 220.04 | -1,059 | 20.38 |
Miscellaneous Cash Flow Adjustments | 0 | - | -0 | 0 |
Net Cash Flow | -2,794 | -10,844 | 19,209 | 255.31 |
Free Cash Flow | 43,452 | 31,798 | -10,079 | 12,231 |
Free Cash Flow Margin | 14.05% | 19.23% | -6.48% | 9.45% |
Free Cash Flow Per Share | 1274.54 | 931.49 | -295.24 | 358.86 |
Cash Interest Paid | 5,693 | 2,893 | 1,391 | 1,210 |
Cash Income Tax Paid | 7,361 | 2,999 | 3,396 | 3,396 |
Levered Free Cash Flow | -16,448 | -10,238 | -9,100 | - |
Unlevered Free Cash Flow | -11,929 | -8,226 | -8,024 | - |
Change in Net Working Capital | 29,097 | 22,848 | 19,835 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.